We are live on
!
Find out more
BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
1-Year Est. Return
64.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.28%
1 Year Est. Return
+64.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$372M
AUM Growth
+$86.6M
(+30%)
Cap. Flow
+$68.5M
Cap. Flow
% of AUM
18.43%
Top 10 Holdings %
Top 10 Hldgs %
46.51%
Holding
36
New
15
Increased
5
Reduced
8
Closed
8
Top Buys
| 1 |
Humana
HUM
|
+$18.6M |
| 2 |
Cigna
CI
|
+$17.2M |
| 3 |
AET
Aetna Inc
AET
|
+$17.1M |
| 4 |
Perrigo
PRGO
|
+$16.2M |
| 5 |
HNT
HEALTH NET INC
HNT
|
+$15.3M |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$16.5M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$15.7M |
| 3 |
AKRX
Akorn Inc
AKRX
|
+$14.3M |
| 4 |
Intuitive Surgical
ISRG
|
+$13.9M |
| 5 |
United Therapeutics
UTHR
|
+$12.9M |
Sector Composition
| 1 | Healthcare | 79.03% |
| 2 | Financials | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cigna
CI
$75.1B
| $20.1M | 5.42% |
+124,312
| New | +$17.2M |
|
|
AET
2
DELISTED
Aetna Inc
AET
| $19.1M | 5.15% |
+150,187
| New | +$17.1M |
|
|
3
Humana
HUM
$46.4B
| $19.1M | 5.15% |
+100,000
| New | +$18.6M |
|
4
Cooper Companies
COO
$14.3B
| $18M | 4.85% |
404,920
+164,920
| +69% | +$7.43M |
|
5
Centene
CNC
$31.5B
| $17M | 4.56% |
421,656
-78,344
| -16% | -$2.81M |
|
|
HNT
6
DELISTED
HEALTH NET INC
HNT
| $16.4M | 4.41% |
+255,814
| New | +$15.3M |
|
7
Viatris
VTRS
$20.2B
| $16.3M | 4.38% |
240,000
-30,000
| -11% | -$2.12M |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $15.9M | 4.27% |
65,638
-1,862
| -3% | -$462K |
|
|
9
Perrigo
PRGO
$1.54B
| $15.7M | 4.23% |
+85,000
| New | +$16.2M |
|
|
RCPT
10
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $15.2M | 4.09% |
80,000
-30,000
| -27% | -$4.96M |
|
|
IPXL
11
DELISTED
Impax Laboratories, Inc.
IPXL
| $14.9M | 4.02% |
325,000
+40,000
| +14% | +$1.9M |
|
12
Vertex Pharmaceuticals
VRTX
$123B
| $14.2M | 3.82% |
115,000
+10,000
| +10% | +$1.26M |
|
13
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.9M | 3.48% |
94,665
+7,165
| +8% | +$888K |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
| $12.6M | 3.39% |
+69,590
| New | +$12M |
|
15
Acadia Pharmaceuticals
ACAD
$4.39B
| $12.6M | 3.38% |
+300,000
| New | +$11.6M |
|
|
CPHD
16
DELISTED
Cepheid Inc
CPHD
| $12.5M | 3.37% |
205,064
+5,064
| +3% | +$289K |
|
17
Alkermes
ALKS
$8.66B
| $12.1M | 3.25% |
187,500
-47,500
| -20% | -$2.91M |
|
18
Edwards Lifesciences
EW
$50.6B
| $11.7M | 3.14% |
490,968
-109,032
| -18% | -$2.46M |
|
19
Nektar Therapeutics
NKTR
$2.27B
| $11.6M | 3.11% |
+61,667
| New | +$10.6M |
|
|
ALR
20
DELISTED
Alere Inc
ALR
| $11.3M | 3.05% |
215,000
-10,000
| -4% | -$503K |
|
21
Teva Pharmaceuticals
TEVA
$37.5B
| $10.3M | 2.78% |
175,000
-30,000
| -15% | -$1.85M |
|
|
SIRO
22
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $10M | 2.7% |
+100,000
| New | +$9.6M |
|
|
THOR
23
DELISTED
THORATEC CORPORATION
THOR
| $9.58M | 2.58% |
+215,000
| New | +$9.41M |
|
24
Smith & Nephew
SNN
$13.2B
| $9.34M | 2.51% |
+275,000
| New | +$9.55M |
|
|
WMGI
25
DELISTED
Wright Medical Group Inc
WMGI
| $9.19M | 2.47% |
+350,000
| New | +$9.25M |
|
Similar funds
BCM
RJA
RP
ACPVT
SFA
KL
KFS
FHC